Related Experiment Videos
Insulin-like growth factor system in neuroblastoma tumorigenesis and apoptosis: potential diagnostic and therapeutic
1German Cancer Research Centre, Division of Cytogenetics, Heidelberg, Germany.
Abstract:
Apoptosis is a cell death program which is modulated by a variety of factors including growth factors, signal transduction molecules and inducers of gene expression or DNA replication. Of particular interest is Type I insulin-like growth factor receptor which contains a tyrosine kinase domain linked to the ras-raf-MAPK cascade. This receptor has antiapoptotic effects in a number of in vivo and in vitro models, thus making IGF-I-R a potential target for gene therapy. Particularly the growth of neuroblastoma depends on IGFs which exert their effect through the Type I IGF receptor. This review highlights the role of the IGF-system in neuroblastoma and points at possible modulators with the aim of inducing differentiation or apoptosis of tumor cells.
Insights
The insulin-like growth factor system (IGF-system) plays a key role in neuroblastoma growth. Targeting the Type I insulin-like growth factor receptor (IGF-I-R) may offer new gene therapy strategies for this cancer.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Apoptosis is a regulated cellular process influenced by growth factors and signaling pathways.
- The Type I insulin-like growth factor receptor (IGF-I-R) is a key signaling molecule with anti-apoptotic effects.
- Neuroblastoma growth is critically dependent on insulin-like growth factors (IGFs) acting via IGF-I-R.
Purpose of the Study:
- To review the role of the IGF-system in neuroblastoma development.
- To explore IGF-I-R as a potential therapeutic target for neuroblastoma.
- To identify modulators that induce tumor cell differentiation or apoptosis.
Main Methods:
- Literature review focusing on the IGF-system and neuroblastoma.
- Analysis of signaling pathways involving IGF-I-R and the ras-raf-MAPK cascade.
- Exploration of therapeutic strategies targeting IGF-I-R.
Main Results:
- The IGF-system is integral to neuroblastoma proliferation and survival.
- IGF-I-R signaling, linked to the ras-raf-MAPK cascade, promotes anti-apoptotic effects.
- The IGF-system presents a viable target for novel neuroblastoma therapies.
Conclusions:
- The IGF-system is a crucial regulator in neuroblastoma.
- Targeting IGF-I-R offers a promising avenue for gene therapy and treatment of neuroblastoma.
- Modulating the IGF-system could induce tumor cell apoptosis or differentiation.